Elizabeth H.Z. Thompson's Net Worth
$6.32 Million
Who is Elizabeth H.Z. Thompson?
Elizabeth H.Z. Thompson has an estimated net worth of $6.32 Million. This is based on reported shares across multiple companies, which include Horizon Therapeutics Public Ltd Co, and IGM Biosciences, Inc..
SEC CIK
Elizabeth H.Z. Thompson's CIK is 0001861477
Past Insider Trading and Trends
2022 was Elizabeth H.Z. Thompson's most active year for acquiring shares with 3 total transactions. Elizabeth H.Z. Thompson's most active month to acquire stocks was the month of December. 2022 was Elizabeth H.Z. Thompson's most active year for disposing of shares, totalling 13 transactions. Elizabeth H.Z. Thompson's most active month to dispose stocks was the month of September. 2023 saw Elizabeth H.Z. Thompson paying a total of $0.00 for 51,697 shares, this is the most they've acquired in one year. In 2023 Elizabeth H.Z. Thompson cashed out on 115,474 shares for a total of $1,697,987.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Horizon Therapeutics Public Ltd Co No price found
EVP, Research & Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -14.57K |
$116.50 | -$1,697,987.50 |
0
|
Oct 6
| |||
Form 4
| -12.07% | -2.00K |
—
|
—
| 14.57K |
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| +137.84% | 9.61K |
$113.80 | -$1,075,296.20 | 16.57K |
Dec 30
| |||
Form 4
| -46.29% | -6.01K |
$85.00 | -$510,598.40 | 6.97K |
Scheduled
|
Jul 19 - Jul 20
| ||
Form 4
| -0.63% | -82.00 |
$85.01 | -$6,970.82 | 12.98K |
Scheduled
|
Jul 7
| ||
Form 4
| -38.28% | -8.10K |
$115.64 | -$936,452.72 | 13.06K |
Scheduled
|
Apr 18
| ||
Form 4
| +49.12% | 6.97K |
$101.84 | -$715,935.20 | 21.16K |
Jan 4 - Jan 5
| |||
Form 4
| -34.71% | -7.54K |
$106.34 | -$802,024.58 | 14.19K |
Aug 5
| |||
Form 4
| +38.93% | 6.09K |
$96.59 | -$578,380.92 | 21.73K |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
IGM Biosciences, Inc. (IGMS) Snapshot price: $10.919
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.45K |
—
|
—
| 1.45K |
Mar 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ACADIA PHARMACEUTICALS INC (ACAD) No price found
EVP, Head Research & Dev
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |